Cornerstone Advisors (Washington)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-67
| Closed | -$5K | – | 808 |
|
|
2019
Q2 | $5K | Sell |
67
-14
| -17% | -$1.05K | ﹤0.01% | 908 |
|
|
2019
Q1 | $8K | Buy |
81
+45
| +125% | +$4.44K | ﹤0.01% | 750 |
|
|
2018
Q4 | $3K | Sell |
36
-18
| -33% | -$1.5K | ﹤0.01% | 821 |
|
|
2018
Q3 | $5K | Buy |
54
+39
| +260% | +$3.61K | ﹤0.01% | 765 |
|
|
2018
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 912 |
|